Focus on Depression & Anxiety Symptoms Solution November 2020 (PDF)
Hestia Insight Inc. Begins Healthcare Operations; Treating Anxiety, Depression; Exploring Alternate Medicine
LAS VEGAS, NV, Oct. 22, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Hestia Insight Inc. (OTC: HSTA) new subsidiary, HSTA Health Inc. (HHI), today announced that it has entered a business partnership with Noether Sciences and Technologies, Inc. HHI will utilize Noether’s IP therapy to treat anxiety and depression and has licensing rights for the therapy throughout the U.S.
Hestia Insight Inc. Begins Healthcare Operations
LAS VEGAS, NV, June 11, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hestia Insight Inc. (OTC: HSTA) today announced that it has entered the healthcare sector to explore emerging healthcare technologies, especially growth companies that own intellectual property.
Hestia Insight Inc. Updates Shareholders
LAS VEGAS, NV, May 26, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Hestia Insight Inc. (OTC: HSTA) Dear Hestia Insight Inc. Shareholders and Interested Investors: We became public in the...
Hestia Investments Inc. Begins Strategic Consulting Agreement for BHPA, Inc.
Las Vegas, Nevada, and Chengdu, China, Dec. 04, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Hestia Insight Inc. (OTC:HSTA) today announced that its wholly owned subsidiary, Hestia Investments Inc.,...
Las Vegas, NV - (NewMediaWire) - August 16, 2019 - Hestia Insight Inc. (OTC:HSTA) today announced that its wholly owned subsidiary, Hestia Investments Inc., has entered into an exclusive strategic consulting agreement with Patient Access Solutions, Inc. Hestia Investments will assist Patient Access Solutions in developing and implementing a new business plan and the Company’s business model ...
Hestia Investments Inc. Begins Assisting, Consulting and Capital Market Services for Companies in Selective Industries
Inc., (SYMBOL:HSTA), has begun providing strategic consulting and capital market advisory services for selective micro, small and medium sized companies in the healthcare, biotech and fintech sectors.
“We will also provide seed capital and mezzanine funding for qualified emerging companies in these three sectors,” said Edward C. Lee, Chairman and CEO.
Mr. Lee is a veteran investment banker and entrepreneur with more than 30-years’ experience managing public and private companies both in U.S. and Greater China. For more information please visit www.hestiainsight.com
("Safe Harbor" Statement under the Private Securities Litigation Reform Act of 1995: This press release contains or may contain forward-looking statements such as statements regarding the Company's growth and profitability, growth strategy, liquidity and access to public markets, operating expense reduction, and trends in the industry in which the Company operates. The forward-looking statements contained in this press release are also subject to other risks and uncertainties, including those more fully described in the Company's filings. The Company assumes no obligation to update these forward-looking statements to reflect actual results, changes in risks, uncertainties or assumptions underlying or affecting such statements, or for prospective events that may have a retroactive effect.)